Tracey H. Taveira, Pharm.D., CDOE

Associate Professor
Department of Pharmacy Practice
ttaveira@uri.edu

Education

Doctor of Pharmacy, University of Rhode Island, 2000

Residency/Fellowship

Pharmacy Practice Residency, University of Rhode Island, 2000-2001

Clinical Practice Site

Veterans Administration Medical Center, Providence, RI

Research Interests

Dr. Taveira’s clinical practice at the Providence VA Medical Center is focused on the provision of pharmaceutical care in the adult ambulatory care setting. Her activities include the provision of direct pharmaceutical care services to high risk patients with chronic conditions, such as hypertension, diabetes, dyslipidemia, and tobacco use in the pharmacist-led Cardiovascular Risk Reduction Clinic (CRRC) and the pharmacist-led group medical visit program. Her research and publications have focused on the evaluation of pharmacist-coordinated cardiac risk reduction care models and the impact of mental health conditions on diabetes and cardiac risk factor control.

Adjunct Associate Professor of Medicine
Warren Alpert School of Medicine of Brown University

Research Enhancement Award Program
Providence Veterans Affairs Medical Center

Brown University and Providence VA Medical Center
Vascular Research Laboratory
www.brown.edu/vrl

Taveira TH, Wu WC, Martin OJ, Schleinitz MD, Friedman P, Sharma SC. Pharmacist-led cardiac risk reduction model. Preventive Cardiology 2006; 9(4):202-8.
 
Martin OJ, Wu WC, Taveira TH, Eaton CB, Sharma SC. Multidisciplinary group behavioral and pharmacologic intervention for cardiac risk reduction in diabetes – A Pilot Study.  Diabetes Educator 2007; 33(1):1118-27.

Pirraglia PA, Taveira TH, Cohen LB, Wu W. The moderating effect of depression diagnosis on the effectiveness of a multi-factorial cardiovascular risk reduction clinic. Preventing Chronic Disease 2008; Oct:5(4):A127

Khatana SM, Taveira TH, Miner MM, Eaton CB, Wu WC. Does Cardiovascular Risk Reduction Alleviate Erectile Dysfunction in Men with Type 2 Diabetes Mellitus? International Journal of Impotence Research 2008; Sep-Oct;20(5):501-6.
 
Taveira TH, Pirraglia PA, Cohen LB, Wu WC. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions. Preventive Cardiology 2008;11(4):195-200.

Pirraglia PA, Taveira TH, Cohen LB, Dooley A., Wu WC. Maintenance of cardiovascular risk goals in veterans with diabetes after discharge from a cardiovascular risk reduction clinic. Preventive Cardiology 2009;12(1):3-8.

Khatana SA, Taveira TH, Choudhary G, Eaton CB, Wu WC. Change in Hemoglobin A1C and C-Reactive Protein Levels in Patients with Diabetes Mellitus. J Cardiometab Synd 2009;4:1-5.

Taveira TH, Cohen LB, Dooley AG, Pirraglia PA, Friedmann PD, Wu WC. Efficacy of a pharmacist-led Group medical intervention program in type 2 diabetes (The Veterans Affairs Multi-disciplinary Education and Diabetes Intervention for Cardiac Risk Reduction Program-VA-MEDIC). Diabetes Educator 2010;36(1):109-17.

Jankowich MD, Taveira TH, Wu, WC. Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: Data from NHANES III. Am J Hypertens 2010; Am J Hypertens 2010;23(6):614-9.

Khatana SA, Taveira TH, Wu WC. The association between C-reactive protein levels and insulin therapy in obese vs. non-obese veterans with type 2 diabetes mellitus. J Clin Hypertens 2010;12(6):462-8.

Cohen LB, Pirraglia PA, Taveira TH, Wu WC. Maintenance of risk factor control in patients with diabetes after discharge from a cardiovascular risk reduction clinic in patients with and without mental health conditions. Ann Pharmacother 2010; May 25, (Epub ahead of print) In press. Manuscript ID File #P034 RR.